Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

IMMU $2.20 0.3800 +20.88%
SCLN $8.76 0.6500 +8.01%
VBLT $3.39 0.2300 +7.28%
PVCT $0.52 0.0298 +6.11%
SNSS $0.79 0.0250 +3.29%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

KITE $41.47 -5.7200 -12.12%
OHRP $3.16 -0.3700 -10.48%
PBYI $39.72 -4.2600 -9.69%
CRIS $1.42 -0.1500 -9.55%
ATRA $17.16 -1.6800 -8.92%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next > | Last >>

Zika Infection Transmitted by Sex Reported in Texas

(New York Times) Feb 2, 2016 - Officials in Dallas reported that a patient with Zika virus was infected after having sex with an ill individual who had returned from a country where Zika was circulating.
read article 



The Startup Tracking ‘Valuable’ Doctors for Big Pharma

(BloombergBusinessweek) Feb 3, 2016 - Zephyr Health says it can determine the value of a doctor’s prescription pad.
read article 



Study by Leading Loyola Thoracic Surgeon Suggests Improvements In How Mesothelioma Is Measured

(Loyola Medicine) Feb 3, 2016 - A new study suggests that significant improvements could be made in the scoring system physicians use to estimate the stage (severity) of mesothelioma, an aggressive and deadly cancer.
read press release 



Congress: Drugmakers Planned Price Increases To Boost Profits

(Detroit Free Press/Associated Press) Feb 2, 2015 - Two drugmakers have made a practice of buying and then dramatically hiking the prices of low-cost drugs given to patients with life-threatening conditions including heart disease, AIDS and cancer, according to excerpts from thousands of documents released by federal lawmakers.
read article 



Sen. Ted Cruz Wants To Change The Way The FDA Approves Drugs

(Forbes) Feb 3, 2016 - Giving Congress the right to overrule FDA approval decisions would make the process more political than scientific.
read article 



Penn Cancer Center Founder Richard "Buz" Cooper Dies

(The Daily Pennsylvanian) Feb 3, 2016 - Recently, the Penn community lost one of its finest members — a doctor, researcher, leader and teacher.
read article 



Government Missed Cancer Waiting Times Target, PM Admits

(The Guardian [UK]) Feb 3, 2016 - David Cameron has said the government needs to improve its performance on cancer waiting times, admitting it had missed a target for patients to be treated within 62 days of an urgent referral from a GP.
read article 



J&J's Talcum Powder Goes on Trial in Ovarian Cancer Lawsuits

(Bloomberg) Feb 2, 2016 - Johnson & Johnson, already facing lawsuits over products from surgical mesh to antipsychotic drugs, began trial Tuesday over claims the talcum powder it marketed to women gave some of them cancer.
read article 



First Patient Treated With LC Bead LUMI™ Radiopaque Embolic Bead Supported by Philips Live Image Guidance

(TheStreet) Feb 3, 2016 - BTG plc, a global specialist healthcare company, and Royal Philips, announced today a significant milestone in their collaboration with the treatment of the first liver cancer patient with LC Bead LUMI™ in conjunction with Philips Live Image Guidance, targeting a hypervascular tumor with the goal to block blood flow to achieve tumor necrosis.
read article 



Morphotek Announces Collaboration with Mayo Clinic to Apply Its Folate Receptor Alpha Diagnostic Assays in a Phase II Clinical Trial in Triple-Negative Breast Cancer

(Morningstar) Feb 3, 2016 - Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it is collaborating with researchers Keith L. Knutson, Ph.D. in the Department of Immunology and Edith A. Perez, M.D. in the Department of Hematology and Oncology at Mayo Clinic in Jacksonville, Florida in a clinical study in patients with folate receptor alpha (FRA) positive, triple-negative breast cancer (TNBC).
read article 



Mersana Therapeutics and Takeda Expand Partnership to Advance Development of Fleximer® Antibody-Drug Conjugates and XMT-1522

(Takeda) Feb 3, 2016 - Mersana Therapeutics and Takeda Pharmaceutical Company Limited today announced that they have entered a new strategic partnership granting Takeda rights to Mersana’s lead product candidate, XMT-1522, outside the United States and Canada.
read corporate press release 



OXiGENE Says FDA Approved Protocol for Phase 2/3 Study of CA4P for Treatment of Platinum-Resistant Ovarian Cancer

(StreetInsider) Feb 3, 2016 - FOCUS will test whether CA4P, the company’s lead investigational drug, improves progression-free survival (PFS) when combined with bevacizumab (Avastin®) and chemotherapy.
read article 



FDA Grants TapImmune Fast Track Designation For Lead Vaccine In Ovarian Cancer

(NASDAQ/RTTNews.com) Feb 3, 2016 - TapImmune Inc., a clinical-stage immuno-oncology company, said that the U.S. Food & Drug Administration or FDA has granted Fast Track Designation for its cancer vaccine TPIV 200 in the treatment of ovarian cancer.
read article 



Trillium Therapeutics Doses First Patient With TTI-621, a Novel Immune Checkpoint Inhibitor Targeting CD47

(CNNMoney) Feb 3, 2016 - Trillium Therapeutics Inc. a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it has initiated dosing in its Phase 1 clinical trial of TTI-621 (SIRPaFc), a novel checkpoint inhibitor of the innate immune system, in relapsed or refractory hematologic malignancies.
read article 



Minority of Cancer Cells Affect The Growth And Metastasis Of Tumors

(Lund University [Sweden]) Feb 2, 2016 - New research shows that a small minority of cancer cells in neuroendocrine tumours of the pancreas contribute to the overall growth and metastasis of the tumour. This discovery was made by a research group at Lund University, in collaboration with researchers at Karolinska Institutet, in Sweden.
read article 



Penn Study Identifies Enzyme Key to Link Between Age-Related Inflammation and Cancer

(Penn Medicine) Feb 2, 2016 - For the first time, researchers have shown that an enzyme key to regulating gene expression -- and also an oncogene when mutated -- is critical for the expression of numerous inflammatory compounds that have been implicated in age-related increases in cancer and tissue degeneration, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
read press release 



Researchers Discover New Way To Screen For Cancer-Killing Drugs

(University of Glasgow [Scotland]) Feb 1, 2016 - A technique called “mito-priming” is the latest method to be developed by researchers in the fight against cancer.
read article 



Cornell Finds Success with Cancer-Inhibiting Protein

(Cornell University/The Cornell Daily Sun) Feb 3, 2016 - A recent Cornell study demonstrates a promising method for killing cancer cells in the bloodstream.
read article 



Immune Therapy for Brain Tumors: A New Promising Avenue

(UNM CCC) Feb 3, 2016 - Clinical Trial update presented by UNM Comprehensive Cancer Center Leaders at international Neuro-Oncology meeting; UNM Comprehensive Cancer Center opens new clinical trial testing immune therapies for glioblastoma.
read press release 



Fertility Issues For Cancer Patients Can Also Bring Legal Headaches

(Reuters Health) Feb 2, 2016 - Reproductive technology has made it easier for cancer survivors to start families despite being infertile after treatment, but some patients may still find their future parenthood plans dashed by legal complications, says a group of U.S. doctors and lawyers.
read article 



Flip Flop: ED Drugs Not Tied to Prostate Cancer Return

(Medscape Medical News) Feb 2, 2016 - Erectile dysfunction (ED) is a common adverse effect of prostate cancer therapy. But is the use of these drugs tied to biochemical recurrence? New evidence counters an earlier study.
read article (free registration required) 



Activity With PD-1 Inhibitors in Upper GI Cancers

(Medscape Medical News) Feb 1, 2016 - Immunotherapy drugs targeting cell programmed death (PD), already marketed for the treatment of melanoma and lung cancer, are making an impact on many other cancer types as well.
read article (free registration required) 



Rate of Office Visits, Cumulative Costs Prior To Colonoscopies For Colon Cancer Screening

(Science Codex) Feb 2, 2016 - Kevin R. Riggs, M.D., M.P.H., of the Johns Hopkins University School of Medicine, Baltimore, and colleagues analyzed billing data to determine the proportion of colonoscopies for colon cancer screening and polyp surveillance that were preceded by office visits and the associated payments for those visits. The study appears in the February 2 issue of JAMA.
read article 



Time Between Positive Fecal Blood Test and Colonoscopy Varies Widely

(AACR) Feb 3, 2016 - Patients who received positive fecal blood test results as part of the screening process for colorectal cancer experienced wide variations in the time between a positive result and a follow-up colonoscopy across four U.S. health care systems, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
read press release 



FDA Places 'Partial Hold' On Drug Trial By Durham's Heat Biologics; Stocks Drop

(Triangle Business Journal) Feb 3, 2016 - The U.S. Food and Drug Administration placed a partial hold on a clinical trial by Durham-based drug developer Heat Biologics, something that sent Heat’s stock down more than 20 percent.
read article